Dr. Montero-Odasso and study participant demonstrate walking and talking gait test

Study participant Roy Bratty, 82, demonstrates the walking and talking gait test with Dr. Manuel Montero-Odasso,a Lawson scientist, geriatrician at St. Joseph’s Health Care London, and associate professor in the Division of Geriatric Medicine at Western University’s Schulich School of Medicine & Dentistry.

Early dementia detection can lead to halting its progression

St. Joseph’s: Parkwood Institute - 

In a new study, researchers at Lawson Health Research Institute and Western University are demonstrating that gait, or motion testing, while simultaneously performing a cognitively demanding task can be an effective predictor of progression to dementia and eventually help with earlier diagnosis. To date, there is no definitive way for health care professionals to forecast the onset of dementia in a patient with memory complaints.

Dr. Lena Palaniyappan

Dr. Palaniyappan wins Canadian College of Neuropsychopharmacology’s 2017 Young Investigator Award

LHSC: Victoria Hospital - 

Lawson associate scientist Dr. Lena Palaniyappan has won the Canadian College of Neuropsychopharmacology (CCNP)’s 2017 Young Investigator Award for outstanding contributions to the field of neuropsychopharmacology.

The Young Investigator Award is given for basic research or clinical research in alternating years. This year’s award was presented for clinical research. Scientists who have completed their post-doctoral or residency training 10 years ago or less are considered for the award.

Older couple jogging with their dog

First study to look at demographics of both stroke and dementia across Ontario since the province pioneered Canada’s first stroke prevention strategy in 2000

LHSC: University Hospital - 

Ontario’s stroke prevention strategy appears to be having an unexpected, beneficial side effect: a reduction also in the incidence of dementia among older seniors.

A new paper by researchers at Western University, Lawson Health Research Institute and the Institute for Clinical Evaluative Sciences (ICES) shows there’s been a decade-long drop in new diagnoses of both stroke and dementia in the most at-risk group ­­—  those who are 80 or older.